Financials

	2022	2023
Net sales	14.52M 12.69M 11.66M 10.87M 20.62M 1.38B 20.93M 140M 54.43M 679M 54.49M 53.32M 2.34B	15.3M 13.37M 12.29M 11.45M 21.73M 1.46B 22.06M 148M 57.35M 716M 57.42M 56.18M 2.47B
Net income	-117M -102M -93.74M -87.38M -166M -11.11B -168M -1.13B -437M -5.46B -438M -429M -18.82B	-101M -88.2M -81.05M -75.55M -143M -9.61B -145M -973M -378M -4.72B -379M -371M -16.27B
Net Debt	-70.34M -61.49M -56.51M -52.67M -99.9M -6.7B -101M -678M -264M -3.29B -264M -258M -11.34B	-1.47M -1.29M -1.18M -1.1M -2.09M -140M -2.12M -14.18M -5.51M -68.8M -5.52M -5.4M -237M

* Estimated data More financial data

Company Profile

DTech Liquidating, Inc., formerly DermTech, Inc., has filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code. The Company has no business operations.

Employees

Sector

Investment Holding Companies

More about the company

Market Cap	35 30.6 28.12 26.21 49.71 3.33K 50.47 337.57 131.23 1.64K 131.38 128.56 5.64K	P/E 2022	-0.46x	P/E 2023	-0.57x
Enterprise Value	-1.47M -1.29M -1.18M -1.1M -2.09M -140M -2.12M -14.18M -5.51M -68.8M -5.52M -5.4M -237M	EV / Sales 2022	-1.16x	EV / Sales 2023	3.82x
Free-Float	98.04%	Yield 2022 *	-	Yield 2023	-

12/08/25	DermTech, Inc. Went Out of Business	CI
22/05/25	Fourth Motion for Exclusivity Period Extension Approved For DermTech, Inc.	CI
01/04/25	Third Motion for Exclusivity Period Extension Approved For DermTech, Inc.	CI
04/03/25	Bankruptcy Judge Changed for DermTech, Inc.	CI
29/01/25	Second Motion for Exclusivity Period Extension Approved For DermTech, Inc.	CI
13/12/24	First Amended Disclosure Statement Approved for DermTech, Inc.	CI
11/12/24	Combined First Amended Joint Liquidation Plan and Disclosure Statement Filed by DermTech, Inc.	CI
13/11/24	Motion for Exclusivity Period Extension Approved For DermTech, Inc.	CI
07/11/24	Joint Liquidation Plan and Disclosure Statement Filed by DermTech, Inc.	CI
27/09/24	First Motion for Exclusivity Period Extension Filed by DermTech, Inc.	CI
30/08/24	DERM-JES Holdings, LLC completed the acquisition of Substantially All Assets from DermTech, Inc. (OTCPK:DMTK.Q).	CI
21/08/24	Motion for Asset Sale Approved for DermTech, Inc.	CI
21/08/24	DERM-JES Holdings, LLC enter into a winning bid to acquire Substantially All Assets from DermTech, Inc. (OTCPK:DMTK.Q).	CI

19/04/24	Lake Street Downgrades DermTech to Hold From Buy, Price Target is $0.63	MT
19/04/24	BTIG Downgrades DermTech to Neutral From Buy	MT
07/03/24	BTIG Adjusts DermTech's Price Target to $2 From $4, Maintains Buy Rating	MT
05/03/24	Stephens Trims Price Target on DermTech to $1.50 From $2.50, Keeps Equalweight Rating	MT
07/08/23	BTIG Adjusts Price Target on DermTech to $5 From $6, Maintains Buy Rating	MT

02/09/24	DermTech Completes Transaction for Asset Sale; Operations Continue Under New Ownership and Management	AQ
18/06/24	DermTech Files for Voluntary Chapter 11 Protection	BU
13/06/24	SciBase strengthens the US organization with experienced leader in dermatology	AQ
14/05/24	DermTech Reports First-Quarter 2024 Financial Results	BU
10/05/24	DermTech : Accelaration/Increase of Financial Obligation - Form 8-K	PU

Manager	Title	Age	Since
Kevin Sun DFI	Director of Finance/CFO	48	12/09/2019
Bill Zondler CTO	Chief Tech/Sci/R&D Officer	-	-
Steven Stone CTO	Chief Tech/Sci/R&D Officer	-	28/07/2022

DermTech, Inc. Stock Nasdaq

Stocks

VGG2379F1247

Investment Holding Companies

Valuation: DermTech, Inc.

Latest news : DermTech, Inc.

Analysts' recommendations: DermTech, Inc.

Press Releases: DermTech, Inc.

Managers and Directors: DermTech, Inc.

Shell Companies

Financials

Company Profile

Director	Title	Age	Since
Matthew Posard CHM	Chairman	58	01/07/2016
Herm Rosenman BRD	Director/Board Member	78	01/01/2017
Cynthia Collins BRD	Director/Board Member	67	24/05/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DERMTECH, INC.	-.--%	-.--%	-	-	35
EINRIDE AB	+9.18%	+10.69%	-	-	1.18B
CHURCHILL CAPITAL CORP XI	+11.96%	+37.81%	-	-	1.06B
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.20%	+0.40%	-	-	643M
CENTIEL AG	-0.32%	-19.32%	+288.68%	-68.79%	628M
CHURCHILL CAPITAL CORP XII	-0.37%	+2.97%	-	-	601M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.29%	+0.10%	-	-	600M
CANTOR EQUITY PARTNERS IV, INC.	-0.10%	+0.44%	-	-	594M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	+0.25%	+3.49%	-	-	586M
Average	+2.34%	+8.88%	+288.68%	-68.79%	737.26M
Weighted average by Cap.	+3.99%	+14.29%	+288.68%	-68.79%